GENSCRIPT BIO (01548): CARVYKTI generated approximately 524 million US dollars in trade sales revenue for the quarter ending September 30, 2025.
Kingray Biotechnology (01548) announced that, according to the agreement with Janssen Biotech, I...
GENSCRIPT BIO(01548) announced that, according to the collaboration and license agreement signed with Janssen Biotech, Inc. on December 21, 2017, CARVYKTI generated net sales of approximately $524 million in the quarter ending on September 30, 2025.
Related Articles
US Stock Market Move | Intended to issue $3.2 billion in bonds to expand data center TeraWulf (WULF.US) rose nearly 9%.
US Stock Market Move | Q2 performances exceed expectations. Albertsons Companies, Inc. Class A (ACI.US) sees significant rebound of over 12%.
US Stock Market Move | Q3 profits exceeded expectations, Telefonaktiebolaget LM Ericsson Sponsored ADR Class B (ERIC.US) rose over 16%.
US Stock Market Move | Intended to issue $3.2 billion in bonds to expand data center TeraWulf (WULF.US) rose nearly 9%.
US Stock Market Move | Q2 performances exceed expectations. Albertsons Companies, Inc. Class A (ACI.US) sees significant rebound of over 12%.
US Stock Market Move | Q3 profits exceeded expectations, Telefonaktiebolaget LM Ericsson Sponsored ADR Class B (ERIC.US) rose over 16%.
RECOMMEND
